The evaluation of five methylation markers, SFRP2, GATA4/5, NDRG4 and VIM, revealed that >96% of patients with CRC and only 35% of normal controls exhibited at least one methylated allele in their fecal samples. The gene discussed is SFRP2; the disease is colorectal carcinoma.